Method for treating obesity, metabolic syndrome and/or non-insulin dependent diabetes mellitus

摘要

A method for treatment of obesity, metabolic syndrome and/or non-insulin dependent diabetes mellitus is described that involves administering a drug capable of modulating the regulation of UCP-2. Methods for screening for potential drugs against obesity, metabolic syndrome and/or non-insulin dependent diabetes mellitus and the use of a cDNA probe for determination of upregulation of UCP-2 for potential drugs against those conditions is also described.